Trial · NCT04701203
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Blinded Period (Weeks 0 to 26) | STARTED | Double Blind: TransCon PTH | 61 | |
| Blinded Period (Weeks 0 to 26) | STARTED | Double Blind: Placebo | 21 | |
| Blinded Period (Weeks 0 to 26) | STARTED | Open-Label Extension Period: TransCon PTH | 0 | |
| Blinded Period (Weeks 0 to 26) | COMPLETED | Double Blind: TransCon PTH | 60 | |
| Blinded Period (Weeks 0 to 26) | COMPLETED | Double Blind: Placebo | 19 | |
| Blinded Period (Weeks 0 to 26) | COMPLETED | Open-Label Extension Period: TransCon PTH | 0 | |
| Blinded Period (Weeks 0 to 26) | NOT COMPLETED | Double Blind: TransCon PTH | 1 | |
| Blinded Period (Weeks 0 to 26) | NOT COMPLETED | Double Blind: Placebo | 2 | |
| Blinded Period (Weeks 0 to 26) | NOT COMPLETED | Open-Label Extension Period: TransCon PTH | 0 | |
| Open-Label Period (Weeks 26 to 182) | STARTED | Double Blind: TransCon PTH | 0 | |
| Open-Label Period (Weeks 26 to 182) | STARTED | Double Blind: Placebo | 0 | |
| Open-Label Period (Weeks 26 to 182) | STARTED | Open-Label Extension Period: TransCon PTH | 79 | |
| Open-Label Period (Weeks 26 to 182) | COMPLETED | Double Blind: TransCon PTH | 0 | |
| Open-Label Period (Weeks 26 to 182) | COMPLETED | Double Blind: Placebo | 0 | |
| Open-Label Period (Weeks 26 to 182) | COMPLETED | Open-Label Extension Period: TransCon PTH | 73 | |
| Open-Label Period (Weeks 26 to 182) | NOT COMPLETED | Double Blind: TransCon PTH | 0 | |
| Open-Label Period (Weeks 26 to 182) | NOT COMPLETED | Double Blind: Placebo | 0 | |
| Open-Label Period (Weeks 26 to 182) | NOT COMPLETED | Open-Label Extension Period: TransCon PTH | 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04701203/flow